Further evidence that methylenetetrahydrofolate reductase A1298C polymorphism is a risk factor for schizophrenia

J Neural Transm (Vienna). 2010 Sep;117(9):1115-7. doi: 10.1007/s00702-010-0442-3. Epub 2010 Aug 6.

Abstract

Previous work suggests that the methylenetetrahydrofolate reductase gene (MTHFR) functional polymorphism A1298C may be a risk factor for schizophrenia. In this study, the genetic association between the MTHFR A1298C polymorphism and schizophrenia was investigated in 379 patients with schizophrenia and 380 age- and sex-matched controls subjects. The results showed an association between the 1298C allele and the disorder (OR 1.39, 95% confidence interval 1.08-1.79). This provides further evidence that the MTHFR A1298C polymorphism may play a role in conferring risk for schizophrenia in the Chinese Han population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People / genetics
  • Chi-Square Distribution
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • Schizophrenia / genetics*

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)